Erectile dysfunction, also referred as impotence, is a medical condition that results in inability to get and keep erection firm during sexual intercourse. Several factors such as hormonal imbalance, insufficient blood flow to penis, conditions affecting the nervous system, and psychological causes such as depression and anxiety are the leading causes of erectile dysfunction. Erectile dysfunction may also be caused by underlying medical conditions such as high blood pressure and cardiovascular diseases. Technological advancement in the field of erectile dysfunction has led to the development of novel treatment devices such as external penile support devices, penile vibrators, and extracorporeal shockwave therapy.
The global erectile dysfunction treatment devices market is projected to be primarily driven by the high prevalence and rising incidences of erectile dysfunction. Around 50% of men aged 40 to 70 years are estimated to suffer from some degree of erectile dysfunction. Incidence of erectile dysfunction increases with the growing age. This is projected to drive the erectile dysfunction treatment devices market during the forecast period. People with lifestyle related risk factors, especially chain smokers, are more susceptible to erectile dysfunction. Technological advancement has led to new product development with higher efficiency and high levels of satisfaction among users.
New product development and approvals for erectile dysfunction treatment such as external penile support devices are estimated to fuel the erectile dysfunction treatment devices market during the forecast period. However, availability of therapeutic drugs and high cost of implantable devices is likely to restrain erectile dysfunction treatment devices market growth in the near future.
Request a PDF Sample – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=42131
The global erectile dysfunction treatment devices market can be segmented based on product type, end-user, and geography. In terms of product type, the global erectile dysfunction treatment devices market can be divided into penile implants, external penile support devices, vacuum constriction devices, and erectile dysfunction shockwave generators. The penile implants segment is expected to account for significant share of the erectile dysfunction treatment devices market during the forecast period. Penile implants are surgical prosthetic devices that are implanted within erection chambers of penis. The penile implants segment can be further bifurcated into inflatable and malleable penile implants.
Malleable implants consist of a set of two cylindrical rods (bendable enough) that is placed in the corpora of penis. Inflatable penile prosthesis consists of two cylindrical rods attached to reservoir and pump. These are surgically implanted into the lower abdomen. Around 80% to 90% men treated with inflatable penile prosthetic device have shown high levels of satisfaction. External support devices are newly invented devices for the treatment of erectile dysfunction. These are worn externally without any surgical interventions. These devices are developed to provide length and rigidity to penis and are worn during the sexual intercourse. Low intensity extracorporeal shockwave therapy is used in erectile dysfunction shockwave generators. This significantly improves the penile hemodynamics and is likely to induce structural changes to regenerate penile tissue. In terms of end-user, the erectile dysfunction treatment devices market can be segregated into hospitals, ambulatory surgery centers, and specialty clinics.
Request for Analysis of COVID19 Impact on Erectile Dysfunction Treatment Devices Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=42131
Based on geography, the global erectile dysfunction treatment devices market can be divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America and Europe are estimated to account for the leading share of the global erectile dysfunction treatment devices market during the forecast period. Currently, more than 18 million men in the U.S. are being affected by erectile dysfunction. This number is expected to rise over the years.
Presence of well-established health care facilities, easy access to health care centers, easy availability of treatment devices, and favorable medical reimbursement policies for implantable penile prosthesis are some of the factors projected to drive the erectile dysfunction treatment devices market in North America & Europe during the forecast period. The erectile dysfunction treatment devices market in Asia Pacific is likely to expand at a fast-paced CAGR during the forecast period.
Pre Book Erectile Dysfunction Treatment Devices Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=42131<ype=S
Key players operating in the global erectile dysfunction treatment devices market include Global Life Technologies, LLC, Coloplast Corp., The Elator, Tyna International Limited, Boston Scientific Corporation, Zephyr Surgical Implants, Promedon Group, STORZ MEDICAL AG, and Augusta Medical Systems.
More Trending Reports by Transparency Market Research –
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Transparency Market Research,
90 Sate Street, Suite 700,
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453